gip and glp-1 agonist The Emerging Role of Dual Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction 𝗧𝗵𝗲 𝗘𝗳𝗳𝗲𝗰𝘁 𝗼𝗳 𝗚𝗟𝗣-𝟭 𝗥𝗲𝗰𝗲𝗽𝘁𝗼𝗿

A GLP-1 Vision Loss Lawsuit is a legal claim filed by individuals who have experienced sudden or permanent vision loss, such as non-arteritic anterior ischemic optic neuropathy (NAION), after using GLP-1 medications like Ozempic, Wegovy, Mounjaro, or Zepbound

Victoza (liraglutide) injection, for subcutaneous use: prescribing information

R., Wefers, J., & Meier, J

Efficacy and safety of GLP-1 receptor agonists as add-on to SGLT2 inhibitors in type 2 diabetes mellitus: a meta-analysis

Ibrahim, A

Mitigating cardiovascular risk in type 2 diabetes with antidiabetes drugs: a review of principal cardiovascular outcome results of EMPA-REG OUTCOME, LEADER, and SUSTAIN-6 trials